Koyfin Home > Directory > Health Care > Abbott Laboratories > Gross Margin

Abbott Laboratories Gross Margin Chart (ABT)

Abbott Laboratories annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Abbott Laboratories Gross Margin for the quarter ending September 09, 2020 was $57m a -2.40% decrease of -1m year over year
  • Abbott Laboratories Gross Margin for the last 12 months ending September 09, 2020 was $57m a -2.46% decrease of -1m year over year
  • Abbott Laboratories Annual Gross Margin for 2019 was $59m a 0.06% increase of 0m from 2018
  • Abbott Laboratories Annual Gross Margin for 2018 was $59m a 0.94% increase of 1m from 2017
  • Abbott Laboratories Annual Gross Margin for 2017 was $58m a 2.79% increase of 2m from 2016
Other Margins & Efficiency Metrics:
  • Abbott Laboratories EBITDA Margin for the quarter ending December 12, 2018 was $25m a 18.35% increase of 5m year over year
  • Abbott Laboratories Return on Capital % for the quarter ending December 12, 2018 was 5.32 a 42.90% increase of 2.28 year over year
  • Abbott Laboratories Return on Equity % for the quarter ending December 12, 2018 was 8.48 a 38.46% increase of 3.26 year over year
View Chart On Koyfin

Quarterly ABT Gross Margin Data

09/2020$57m
06/2020$55m
03/2020$58m
12/2019$59m
09/2019$58m
06/2019$59m
03/2019$58m
12/2018$60m
09/2018$59m
06/2018$58m

Annual ABT Gross Margin Data

2019$59m
2018$59m
2017$58m
2016$56m
2015$57m
2014$55m
2013$53m
2012$54m
2011$53m
2010$59m